The long-running patent battle over CRISPR, the genome editor that may bring a Nobel prize and many millions of dollars to whomever is credited with its invention, has taken a new twist that vastly complicates the claims made by a team led by the University of California.

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *